Blog

The market expects Progress Software (PRGS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended May 2025. This widely-known consensus

Investors in Rogers Communications Inc. RCI need to pay close attention to the stock based on moves in the options market lately. That is because the July 18, 2025 $40.00 Put had some of the highest

Lam Research Corporation LRCX has had a strong run so far this year, rallying 25.3%. This is well ahead of the Zacks Electronics – Semiconductors industry, which has risen just 5.1% during the same

Shares of Euroseas Ltd. (ESEA) have gained 18.4% over the past four weeks to close the last trading session at $44.78, but there could still be a solid upside left in the stock if short-term price

Consensus Cloud Solutions, Inc. (CCSI) closed the last trading session at $21.91, gaining 2.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Shares of Mama's Creations, Inc. (MAMA) have gained 11% over the past four weeks to close the last trading session at $7.90, but there could still be a solid upside left in the stock if short-term

From a technical perspective, QIAGEN N.V. (QGEN) is looking like an interesting pick, as it just reached a key level of support. QGEN's 50-day simple moving average crossed above its 200-day simple

Nice (NICE) closed the last trading session at $162.61, gaining 1.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

HUTCHMED (HCM) closed the last trading session at $14.84, gaining 10.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Kimbell Royalty (KRP) closed the last trading session at $14.61, gaining 11.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Micron Technology, Inc. MU will report third-quarter fiscal 2025 results on June 25, after market close.

The company projects fiscal third-quarter revenues to be $8.8 billion (+/- $200 million). The

Incyte INCY announced that the FDA has extended the review period for the supplemental new drug application (sNDA) for ruxolitinib cream.

The sNDA is seeking approval of the cream for the treatment

Toyota Motor Corporation TM will increase prices for select vehicles in the United States by more than $200, starting in July. Prices of Toyota-branded models will rise by an average of $270. While

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Tandem Diabetes Care, Inc.’s TNDM t:slim X2 insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now compatible with Abbott’s FreeStyle Libre 3 Plus continuous glucose